Requires written notification where a pharmacist is substituting a generic version of a drug product by one manufacturer for a generic version of a drug product by another
Summary
Requires written notification to patients where a pharmacist is substituting a generic version of a drug product by one manufacturer for a generic version of a drug product by another manufacturer.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2017
Committee Review
Floor Vote
Governor
Introduced Feb 1, 2017
Last action Jan 3, 2018
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
2
Jan 3, 2018
Assembly · Referred to committee
REFERRED TO HIGHER EDUCATION
Feb 1, 2017
Assembly · Referred to committee
REFERRED TO HIGHER EDUCATION
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Linda Rosenthal
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about A 4161
Scope: NY
Hi! I can help you understand A 4161. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline